Hide metadata

dc.date.accessioned2023-01-03T17:43:29Z
dc.date.available2023-01-03T17:43:29Z
dc.date.created2022-11-10T12:28:41Z
dc.date.issued2023
dc.identifier.citationMahamat-Saleh, Yahya Al-Rahmoun, Marie Severi, Gianluca Ghiasvand, Reza Veierød, Marit Bragelien Caini, Saverio Palli, Domenico Botteri, Edoardo Sacerdote, Carlotta Ricceri, Fulvio Lukic, Marko Sánchez, Maria J. Pala, Valeria Tumino, Rosario Chiodini, Paolo Amiano, Pilar Colorado-Yohar, Sandra Chirlaque, María-Dolores Ardanaz, Eva Bonet, Catalina Katzke, Verena Kaaks, Rudolf Schulze, Matthias B. Overvad, Kim Dahm, Christina C. Antoniussen, Christian S. Tjønneland, Anne Kyrø, Cecilie Bueno-de-Mesquita, Bas Manjer, Jonas Jansson, Malin Esberg, Anders Mori, Nagisa Ferrari, Pietro Weiderpass, Elisabete Boutron-Ruault, Marie-Christine Kvaskoff, Marina . Baseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC). International Journal of Cancer. 2022
dc.identifier.urihttp://hdl.handle.net/10852/98465
dc.description.abstractExperimental evidence suggests that alcohol induces cutaneous carcinogenesis, yet epidemiological studies on the link between alcohol intake and skin cancer have been inconsistent. The European Prospective Investigation into Cancer and Nutrition (EPIC) is a prospective cohort initiated in 1992 in 10 European countries. Alcohol intake at baseline and average lifetime alcohol intake were assessed using validated country-specific dietary and lifestyle questionnaires. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated in Cox models. A total of 14 037 skin cancer cases (melanoma: n = 2457; basal-cell carcinoma (BCC): n = 8711; squamous-cell carcinoma (SCC): n = 1928; unknown: n = 941) were identified among 450 112 participants (average follow-up: 15 years). Baseline alcohol intake was positively associated with SCC (>15 vs 0.1-4.9 g/day: HR = 1.44, 95% CI = 1.17-1.77; Ptrend = .001), BCC (HR = 1.12, 95% CI = 1.01-1.23; Ptrend = .04), and melanoma risks in men (HR = 1.17, 95% CI = 0.95-1.44; Ptrend = .17), while associations were more modest in women (SCC: HR = 1.09, 95% CI = 0.90-1.30; Ptrend = .13; BCC: HR = 1.08, 95% CI = 1.00-1.17, Ptrend = .03; melanoma: HR = 0.93, 95% CI = 0.80-1.08, Ptrend = .13). Associations were similar for lifetime alcohol intake, with an attenuated linear trend. Lifetime liquor/spirit intake was positively associated with melanoma (fourth vs first quartile: HR = 1.47, 95% CI = 1.08-1.99; Ptrend = .0009) and BCC risks in men (HR = 1.17, 95% CI = 1.04-1.31; Ptrend = .14). Baseline and lifetime intakes of wine were associated with BCC risk (HR = 1.25 in men; HR = 1.11-1.12; in women). No statistically significant associations were found between beverage types and SCC risk. Intake of beer was not associated with skin cancer risk. Our study suggests positive relationships between alcohol intake and skin cancer risk, which may have important implications for the primary prevention of skin cancer.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleBaseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)
dc.title.alternativeENEngelskEnglishBaseline and lifetime alcohol consumption and risk of skin cancer in the European Prospective Investigation into Cancer and Nutrition cohort (EPIC)
dc.typeJournal article
dc.creator.authorMahamat-Saleh, Yahya
dc.creator.authorAl-Rahmoun, Marie
dc.creator.authorSeveri, Gianluca
dc.creator.authorGhiasvand, Reza
dc.creator.authorVeierød, Marit Bragelien
dc.creator.authorCaini, Saverio
dc.creator.authorPalli, Domenico
dc.creator.authorBotteri, Edoardo
dc.creator.authorSacerdote, Carlotta
dc.creator.authorRicceri, Fulvio
dc.creator.authorLukic, Marko
dc.creator.authorSánchez, Maria J.
dc.creator.authorPala, Valeria
dc.creator.authorTumino, Rosario
dc.creator.authorChiodini, Paolo
dc.creator.authorAmiano, Pilar
dc.creator.authorColorado-Yohar, Sandra
dc.creator.authorChirlaque, María-Dolores
dc.creator.authorArdanaz, Eva
dc.creator.authorBonet, Catalina
dc.creator.authorKatzke, Verena
dc.creator.authorKaaks, Rudolf
dc.creator.authorSchulze, Matthias B.
dc.creator.authorOvervad, Kim
dc.creator.authorDahm, Christina C.
dc.creator.authorAntoniussen, Christian S.
dc.creator.authorTjønneland, Anne
dc.creator.authorKyrø, Cecilie
dc.creator.authorBueno-de-Mesquita, Bas
dc.creator.authorManjer, Jonas
dc.creator.authorJansson, Malin
dc.creator.authorEsberg, Anders
dc.creator.authorMori, Nagisa
dc.creator.authorFerrari, Pietro
dc.creator.authorWeiderpass, Elisabete
dc.creator.authorBoutron-Ruault, Marie-Christine
dc.creator.authorKvaskoff, Marina
cristin.unitcode185,51,15,2
cristin.unitnameEpiStat
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.cristin2071791
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=International Journal of Cancer&rft.volume=&rft.spage=&rft.date=2022
dc.identifier.jtitleInternational Journal of Cancer
dc.identifier.volume152
dc.identifier.issue3
dc.identifier.startpage348
dc.identifier.endpage362
dc.identifier.pagecount0
dc.identifier.doihttps://doi.org/10.1002/ijc.34253
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0020-7136
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International